Resolution of the Interdisciplinary Expert Council «Management of metabolic health as the basis of age-related diseases. Focus on active longevity»

  • Authors: Martynov A.I1, Demidova T.Y.2, Balan V.E3,4, Adasheva T.V5, Tapilskaya N.I6,7, Moskvicheva Y.B8, Kuznetsova P.I9, Balan P.V10
  • Affiliations:
    1. RSMSIM
    2. N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia
    3. Moscow Regional Scientific Research Institute of Obstetrics and Gynecology
    4. M.F. Vladimirsky Moscow Regional Research and Clinical Institute
    5. A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia
    6. Saint Petersburg State Pediatric Medical University
    7. D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology
    8. Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Healthcare of Russia
    9. Scientific Center of Neurology of the Ministry of Healthcare of Russia
    10. Higher School of Economics
  • Issue: Vol 8, No 8 (2022)
  • Pages: 114-119
  • Section: Articles
  • URL: https://journals.eco-vector.com/2412-4036/article/view/276896
  • DOI: https://doi.org/10.18565/therapy.2022.8.114-119
  • ID: 276896

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Full Text

Restricted Access

About the authors

A. I Martynov

RSMSIM

MD, professor, academician of the RAS, president of the RSMSIM, doctor of the highest category in the specialties «Therapy» and «Cardiology», academician of the International Academy of Information Processes and Technologies, Honored Scientist of the Russian Federation, Honored Doctor of the RSFSR, laureate of the Prize of the Council of Ministers of the USSR

T. Yu Demidova

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

MD, professor, head of the Department of endocrinology

V. E Balan

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology; M.F. Vladimirsky Moscow Regional Research and Clinical Institute

MD, professor, president of the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, honorary president of the Russian Menopause Association, head of the Outpatient Department; professor of the Department of obstetrics and gynecology

T. V Adasheva

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

MD, professor, professor of the Department of polyclinic therapy

N. I Tapilskaya

Saint Petersburg State Pediatric Medical University; D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

MD, obstetrician-gynecologist of the highest category, professor of the Department of obstetrics and gynecology; leading researcher

Yu. B Moskvicheva

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Healthcare of Russia

PhD in Medicine, dietitian, employee

P. I Kuznetsova

Scientific Center of Neurology of the Ministry of Healthcare of Russia

PhD in Medicine, researcher

P. V Balan

Higher School of Economics

PhD in Biology, neurophysiologist, MBA, PCC ICF coach, associate professor of the Faculty of biology and biotechnology

References

  1. WHO European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe. 2022. Licence: CC BY-NC-SA 3.0 IGO. URL: https://apps.who.int/iris/bitstream/handle/10665/353747/9789289057738-eng.pdf (date of access - 1 5.10.2022).
  2. Kontsevaya A., Shalnova S., Deev A. et al. Overweight and obesity in the Russian population: Prevalence in adults and association with socioeconomic parameters and cardiovascular risk factors. Obes Facts. 2019; 12(1): 103-14. https://dx.doi.org/10.1159/000493885.
  3. WHO basic documents. URL: https://apps.who.int/gb/bd/(date of access - 1 5.10.2022).
  4. Vermeer S.E., William T., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: A systematic review. Lancet Neurol. 2007; 6(7): 611-19. https://dx.doi.org/10.1016/S1474-4422(07)70170-9.
  5. Драпкина О.М., Самородская И.В., Старинская М.А. ссоавт. Ожирение: оценка и тактика ведения пациентов. Коллективная монография. М.: ФГБУ «НМИЦ ТПМ» Минздрава России; ООО «Силицея-Полиграф». 2021; с. 174. [Drapkina O.M., Samorodskaya I.V., Starinskaya M.A. et al. Obesity: evaluation and management of patients. Collective monograph. Moscow: National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of Russia; Silitseya-Poligraf LLC. 2021; p. 174 (In Russ.)]. ISBN: 978-5-9907556-0-4.
  6. Концепция политики активного долголетия. Научно-методологический доклад к XXI Апрельской международной научной конференции по проблемам развития экономики и общества. под ред. Л. Н. Овчаровой, М. А. Морозовой, О. В. Синявской. М.: Издательский дом Высшей школы экономики. 2020; 40 с. [The concept of active longevity policy. Scientific and methodological report for the XXI April international scientific conference on the problems of economic and social development. Ed. by Ovcharova L.N., Morozova M.A., Sinyavskaya O.V. Moscow: Publishing house of the Higher School of Economics. 2020; 140 pp. (In Russ.)]. https://dx.doi.org/10.17323/978-5-7598-2173-1.
  7. Клинические рекомендации. Ожирение. Российская ассоциация эндокринологов, Общество бариатрических хирургов. Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 28. Доступ: https://cr.minzdrav.gov.ru/schema/28_2 (дата обращения - 11.10.2022).
  8. Дедов И.И. Шестакова М.В., Мельниченко Г.А. с соавт. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний». Ожирение и метаболизм. 2021; 18(1): 5-99. [Dedov I.I., Shestakova M.V., Melnichenko G.A. et al. Interdisciplinary clinical practice guidelines «Management of obesity and its comorbidities». Ozhireniye i metabolism = Obesity and Metabolism. 2021; 18(1): 5-99 (In Russ.)]. https://dx.doi.org/10.14341/omet12714. EDN: AHSBSE.
  9. Heymsfield S.B., Wadden T.A. Mechanisms, pathophysiology, and management of obesity. N. Engl J. Med. 2017; 376(3): 254-66. https://dx.doi.org/10.1056/NEJMra1514009.
  10. Durrer Schutz D., Busetto L., Dicker D. et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019; 12(1): 40-66. https://dx.doi.org/10.1159/000496183.
  11. Wharton S., Lau D.C.W., Vallis M. et al. Obesity in adults: A clinical practice guideline. CMAJ. 2020; 192(31): E875-E891. https://dx.doi.org/10.1503/cmaj.191707.
  12. Bray G.A., Heisel W.E., Afshin A. et al. The science of obesity management: An endocrine society scientific statement. Endocr Rev. 2018; 39(2): 79-132. https://dx.doi.org/10.1210/er.2017-00253.
  13. Лавренова Е.А., Драпкина О.М. Инсулинорезистентность при ожирении: причины и последствия. Ожирение и метаболизм. 2020; 17(1): 48-55. [Lavrenova E.A., Drapkina O.M. Insulin resistance in obesity: pathogenesis and effects. Ozhireniye i metabolism = Obesity and Metabolism. 2020; 17(1): 48-55 (In Russ.)]. https://dx.doi.org/10.14341/omet9759. EDN: WCSRAE.
  14. Belikov A.V. Age-related diseases as vicious cycles. Ageing Res Rev. 2019; 49: 11-26. https://dx.doi.org/10.1016/j.arr.2018.11.002.
  15. Пьяных О.П., Гусенбекова Д.Г., Аметов А.С. Преимущества долгосрочного управления метаболическим здоровьем у пациентов с ожирением и ранними нарушениями углеводного обмена. Эндокринология: новости, мнения, обучение. 2020; 9(2): 40-48. [Pyanykh O.P., Gusenbekova D.G., Ametov A.S. Advantages of long-term management the metabolic health in patients with obesity and early disorders of carbohydrate metabolism. Endokrinologiya: novosti, mneniya, obucheniye = Endocrinology: News, Opinions, Training. 2020; 9(2): 40-48 (In Russ.)]. https://dx.doi.org/10.33029/2304-9529-2020-9-2-40-48. EDN: UKKRHH.
  16. Аметов А.С., Пьяных О.П., Невольникова А.О. Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена. Эндокринология: новости, мнения, обучение. 2020; 9(1): 17-26. [Ametov A.S., Pyanykh O.P., Nevolnikova A.O. Modern opportunities of metabolic health management in patients with obesity and carbohydrate metabolism disorders. Endokrinologiya: novosti, mneniya, obucheniye = Endocrinology: News, Opinions, Training. 2020; 9(1): 17-26 (In Russ.)]. https://dx.doi.org/10.33029/2304-9529-2020-9-1-17-26. EDN: CJCTPR.
  17. Максим О.В., Салухов В.В. От нарушений пищевого поведения к ожирению: вопросы диагностики и нейроэндокринной регуляции. Consilium Medicum. 2022; 24(4): 234-241. [Maksim O.V., Salukhov V.V. From eating to obesity: issues of diagnosis and neuroendocrine regulation. A review. Consilium Medicum. 2022; 24(4): 234-241 (In Russ.)]. https://dx.doi.org/10.26442/20751753.2022.4.201543. EDN: PFAPRZ.
  18. Матвеев Г.А., Голикова Т.И., Васильева А.А. с соавт. Сравнение эффектов терапии ожирения лираглутидом и сибутрамином. Ожирение и метаболизм. 2021; 18(2): 218-228. https://dx.doi.org/10.14341/omet12498. EDN: VILJZF.
  19. Матвеев Г.А., Бабенко А.Ю. Эффективность применения сибутрамина при различных типах нарушений пищевого поведения у пациентов с ожирением. Медицинский совет. 2022; 16(10): 140-147. https://dx.doi.org/10.21518/2079-701X-2022-16-10-140-147. EDN: YVEXCR.
  20. Шишкова В.Н. Ожирение в зеркале психоэмоциональных нарушений: фокус на фармакотерапию. Фармация и фармакология. 2022; 10(1): 19-30. [Shishkova V.N. Obesity as a reflection of psycho-emotional disorders: focus on pharmacotherapy. Farmatsiya i farmakologiya = Pharmacy and Pharmacology. 2022; 10(1): 19-30 (In Russ.)]. https://dx.doi.org/10.19163/2307-9266-2022-10-1-19-30. EDN: EZCDXP.
  21. Демидова Т.Ю., Измайлова М.Я., Ушакова С.Е. с соавт. Оценка эффективности снижения веса и безопасности применения сибутраминсодержащих лекарственных препаратов у пациентов с алиментарным ожирением. Фармация и фармакология. 2022; 10(3): 289-304. [DEmidova T.Yu., Izmailova M.Ya., Ushakova S.E. et al. Evaluation of weight reduction efficacy and safety of sibutramin-containing drugs in patients with alimentary obesity. Farmatsiya i farmakologiya = Pharmacy and Pharmacology. 2022; 10(3): 289-304 (In Russ.)]. https://dx.doi.org/10.19163/2307-9266-2022-10-3-289-304. EDN: QTONFY.
  22. Кузнецова П.И., Танашян М.М., Романцова Т.И. с соавт. Функциональная МР-томография головного мозга на фоне медикаментозной коррекции ожирения. Ожирение и метаболизм. 2022; 19(1): 74-82. [Kuznetsova P.I., Romantsova T.I., Logvinova O.V. et al. Functional brain MRI in the setting of drug correction of obesity. Ozhireniye i metabolism = Obesity and Metabolism. 2022; 19(1): 74-82 (In Russ.)]. https://dx.doi.org/10.14341/omet12810. EDN: ZARJNG.
  23. Государственный реестр лекарственных средств Минздрава России. Препараты с МНН сибутрамин. Доступ: https://grls.rosminzdrav.ru (дата обращения - 01.11.2022).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies